National Aesthetic Spa Network
JUNE 14, 2024
The skin is the largest organ in the human body and is made up of several layers that work together to protect the body from harmful environmental factors and regulate internal temperature. The three main … Continue reading How the skin works by Rena Levi The post How the skin works by Rena Levi appeared first on NASNPRO - National Aesthetic Spa Network.
Lipgloss and Aftershave
JUNE 14, 2024
Tiffany Underwood is one of L+A’s 10 Estheticians To Watch! She’s an award-winning esthetician, she’s a medical spa owner, and she founded a non-profit for cancer patients! She’s also a huge fan of Celluma LED Light Therapy devices and uses them in 99% of her treatments! Thanks to Celluma LED Light Therapy for sponsoring this content so that L+A can share Tiffany’s story with our community.
Dermatology Times
JUNE 14, 2024
In case you missed it, this week had news about the 2024 Revolutionizing Alopecia Areata, Vitiligo, and Eczema Conference, the FDA-approved expanded use of tirbanibulin for actinic keratosis, FDA and EMA support of continuing MoonLake's phase 3 trial of sonelokimab for PsA, and more.
Salon Today
JUNE 14, 2024
Grow's Antony Whitaker reviews Mario Verrilli's book which is a self-described step-by-step guide to the future of the beauty salon industry.
Dermatology Times
JUNE 14, 2024
The organizations called for skin health to be considered a global public health priority in a recent side meeting at the World Health Assembly.
Alison Bladh
JUNE 14, 2024
Spinach and Strawberry Salad This Spinach and Strawberry Salad is a delightful blend of fresh, sweet, and tangy flavours. Perfect for a quick lunch or a light dinner, it’s as beautiful as it is nutritious. Enjoy it on its own or pair it with your favourite protein source, like grilled chicken or tofu for a vegan option. Ingredients • 4 cups (960 ml) fresh spinach leaves • 1 cup (240 ml) strawberries, sliced • 1/4 cup (60 ml) red onion, thinly sliced • 1/4 cup (60 ml) slivered almonds • 1/4 cup (
Esthetician Leadership Today brings together the best content for skin care professionals from the widest variety of industry thought leaders.
Dermatology Times
JUNE 14, 2024
Researchers compared the examination's content outline with data on skin diseases in a recent study.
Mindbody
JUNE 14, 2024
Learn how to open a gym with our step-by-step guide. From finding your niche and funding to building a team, turn your passion into a successful business.
Dermatology Times
JUNE 14, 2024
Although acne is common for most people to experience in their lifetime, it is important to individualize treatment and provide appropriate care when working with a diverse patient base.
Mindbody
JUNE 14, 2024
Learn how to open a gym with our step-by-step guide. From finding your niche and funding to building a team, turn your passion into a successful business.
Beauty Launchpad
JUNE 14, 2024
Get to know Steph Carrillo (@modestspotcarrillo). She is a hairstylist, educator and owner of Modest Spot Salon in Clemente, CA.
Mindbody
JUNE 14, 2024
Learn how to open a gym with our step-by-step guide. From finding your niche and funding to building a team, turn your passion into a successful business.
Dermatology Times
JUNE 14, 2024
The program’s creator, Hubert Greenway, MD, has personally trained each of the fellowship’s 68 physicians in Mohs surgery.
The Dermatology Digest
JUNE 14, 2024
Jonathan Silverberg, MD, PhD, MPH, Director of Clinical Research at The George Washington University School of Medicine and Health Sciences in Washington, DC, breaks down the new data from LEVEL-UP, a head-to-head study evaluating upadacitinib (Rinvoq, AbbVie) vs. dupilumab (Dupixent, Sanofi & Regeneron) for the treatment of adolescents and adults with moderate to severe atopic dermatitis who had inadequate response to systemic therapy or when systemic therapies were not advised.
Dermatology Times
JUNE 14, 2024
Weekend treatment with cyclosporine may be beneficial for patients with moderate to severe psoriasis, according to a new study.
The Dermatology Digest
JUNE 14, 2024
The U.S. Food and Drug Administration (FDA) has cleared InnoCare Pharma’s investigational new drug application (IND) for ICP-332, a tyrosine kinase 2 (TYK2) inhibitor that’s being studied in moderate to severe atopic dermatitis (AD). Currently, no TYK2 inhibitors have obtained marketing approval for the treatment of AD. ICP-332 achieved multiple efficacy endpoints in the China Phase II study of patients with moderate-to-severe AD and demonstrated an “outstanding” and safety profile.
Dermatology Times
JUNE 14, 2024
Two new forms of Trichophyton mentagrophytes type VII and Trichophyton indotineae are emerging, according to a new report.
Expert insights. Personalized for you.
91 
Let's personalize your content